Crizotinib과 한방치료를 병행하여 호전된 ROS1 양성 재발성 폐암 환자 1례
A Case Report on ROS1-positive Recurrent Non-small-cell Lung Cancer Treated with Crizotinib and Korean Medicine
2
조회
0
다운로드
1
인용
0
참고문헌
키워드
초록
Objectives: This study examined the case of a patient with ROS1-positive recurrent non-small-cell lung cancer treated with crizotinib and traditional Korean medicine. Methods: The patient was treated with crizotinib from January 20 2021 to May 22 2021, together with Haedogyangpye-tang and Haengso-tang. The tumor size was measured using computed tomography (CT), and adverse events were evaluated according to the National Cancer Institute’s Common Terminology Criteria for Adverse Events (NCI-CTCAE) version 5.0. Results: After four months of combined treatment, the sizes of the lymph nodes in the porta hepatis, hepatoduodenal, retrocrural, aortocaval, and para-aortic areas had decreased, and no lymph nodes larger than 1 cm in diameter were observed. The side effects of chemotherapy also improved. Conclusions: This case study suggests that traditional Korean medicine may alleviate the side effects of chemotherapy, improve quality of life, and complement chemotherapy itself.
Abstract
Objectives: This study examined the case of a patient with ROS1-positive recurrent non-small-cell lung cancer treated with crizotinib and traditional Korean medicine. Methods: The patient was treated with crizotinib from January 20 2021 to May 22 2021, together with Haedogyangpye-tang and Haengso-tang. The tumor size was measured using computed tomography (CT), and adverse events were evaluated according to the National Cancer Institute’s Common Terminology Criteria for Adverse Events (NCI-CTCAE) version 5.0. Results: After four months of combined treatment, the sizes of the lymph nodes in the porta hepatis, hepatoduodenal, retrocrural, aortocaval, and para-aortic areas had decreased, and no lymph nodes larger than 1 cm in diameter were observed. The side effects of chemotherapy also improved. Conclusions: This case study suggests that traditional Korean medicine may alleviate the side effects of chemotherapy, improve quality of life, and complement chemotherapy itself.
참고문헌 (34)
- Sung HA, "Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries", CA Cancer J Clin, 71(3), pp.209~249 (2021)
- "Lung Cancer" (2021)[URL]
- Soda M, "Identification of the transforming EML4-ALK fusion gene in non-small-cell lung cancer", Nature, 448(7153), pp.561~566 (2007)
- Collisson E, "Comprehensive molecular profiling of lung adenocarcinoma", Nature, 511(7511), pp.543~550 (2014)
- Rikova K, "Global survey of phosphotyrosine signaling identifies oncogenic kinases in lung cancer", Cell, 131(6), pp.1190~1203 (2007)
- Gainor JF, "ALK rearrangements are mutually exclusive with mutations in EGFR or KRAS: an analysis of 1,683 patients with non-small cell lung cancer", Clin Cancer Res, 19(15), pp.4273~4281 (2013)
- Shaw AT, "Crizotinib in ROS1-rearranged non-small-cell lung cancer", N Engl J Med, 371(21), pp.1963~1971 (2014)
- Drilon A, "Safety and antitumor activity of the multitargeted pan-TRK, ROS1, and ALK inhibitor entrectinib: combined results from two phase I trials(ALKA-372-001 and STARTRK-1)", Cancer Discov, 7(4), pp.400~409 (2017)
- Park JW, "One Case Study of a Non Small Cell Lung Cancer Patient Experiencing Gefitinib Adverse Effects Managed by Traditional Korean Medicine", J of Kor Traditional Oncology, 17(1), pp.9~16 (2012)
- 심소현, "Pembrolizumab 면역치료를 시행 중인 비소세포성 폐암환자의 한방치료 증례보고", 대한한방내과학회지, 40(4), pp.709~722 (2019), 대한한방내과학회[DOI]
- Li SG, "The efficacy of Chinese herbal medicine as an adjunctive therapy for advanced non-small cell lung cancer: a systematic review and meta-analysis", PLoS One, 8(2), pp.e57604~ (2013)
- Sohaib A, "RECIST rules", Cancer Imaging, 12(2), pp.345~346 (2012)
- Watanabe H, "New Response Evaluation Criteria in Solid Tumours-Revised RECIST Guideline(version 1.1)", Cancer & chemotherapy, 36(13), pp.2495~2501 (2009)
- "Common Terminology Criteria for Adverse Events (CTCAE)" (2020)[URL]
- National Comprehensive Cancer Network, "Non-Small Cell Lung Cancer Metastatic", ~ (2021)
- 윤탁, "진행성 비소세포폐암의 표적치료 및 맞춤항암치료", 대한내과학회지, 77(1), pp.9~17 (2009), 대한내과학회
- 김균하, "Afatinib 표적항암치료를 시행 중인 흉막 전이된 비소세포폐암 환자의 한방치료 증례보고", 대한한방내과학회지, 41(6), pp.1255~1264 (2020), 대한한방내과학회[DOI]
- Camidge DR, "Activity and safety of Crizotinib in patients with ALK-positive non-small-cell lung cancer:updated results from a phase 1study", Lancet Oncol, 13(10), pp.1011~1019 (2012)
- Jung DS, "Factors Affecting Crizotinib-Induced Hepatotoxicity In Non-small Cell Lung Cancer Patients", Med Oncol, 35(12), pp.154~ (2018)
- Dodd MJ, "Symptom clusters and their effect on the functional status of patients with cancer", Oncol Nurs Forum, 28(3), pp.465~470 (2001)
- Wu X, "Chinese Herbal Medicine for Improving Quality of Life Among Nonsmall Cell Lung Cancer Patients: Overview of Systematic Reviews and Network Meta-Analysis", Medicine, 95(1), pp.e2410~ (2016)
- Li TM, "Characteristics of Chinese herbal medicine usage and its effect on survival of lung cancer patients in Taiwan", Journal of ethnopharmacology, 213, pp.92~100 (2018)
- Jeon JC, "Effects of Several Medicine Herb Prescriptions on Lung Carcinoma Cells", J Int Korean Med, 21(4), pp.621~631 (2000)
- Chen S, "Integrated Chinese and Western Medicine Treatment of Tumor", pp.336~341 (2001), People's Medical Publishing House
- 한인선, "항암제로 유발된 백혈구감소증 회복에 미치는 황기의 효과", 대한한방내과학회지, 27(3), pp.579~588 (2006), 대한한방내과학회
- 이성옥, "백출 추출물의 암세포증식 저해 효과", 생약학회지, 36(3), pp.201~204 (2005), 한국생약학회
- 박가영, "Inhibitory Effect of Dendrobium moniliforme on NO and IL-1β Production in LPS-stimulated Macrophages", 한방안이비인후피부과학회지, 22(3), pp.11~19 (2009), 대한한방안이비인후피부과학회
- 이지영, "桔梗이 免疫活性 및 抗癌에 미치는 영향", 대한한방부인과학회지, 23(4), pp.10~19 (2010), 대한한방부인과학회
- 정진우, "동충하초 유래 cordycepin의 항암 활성 기전 최근 연구 동향", 생명과학회지, 25(5), pp.607~614 (2015), 한국생명과학회
- 김강태, "산두근 추출물이 인체폐암세포의 COX-2 발현 및 PGE2 생성에 미치는 영향", 동의생리병리학회지, 21(4), pp.907~915 (2007), 한의병리학회
- "Korean J Biotechnol Bioeng", 2001, 547~553
- 서운교, "杏蘇湯 및 取淵湯이 호흡기 뮤신 유전자의 발현과 점액분비에 미치는 영향", 대한한의학회지, 29(3), pp.76~87 (2008), 대한한의학회
- Kasymjanova G, "The potential role for acupuncture in treating symptoms in patients with lung cancer: an observational longitudinal study", Curr Oncol, 20(3), pp.152~157 (2013)
- 김옥, "The Study on Acute and Subacute Toxicity and Sarcoma-180 Anti-cancer Effects of Armeniacae amarum semen Herbal-Acupuncture(Haeng-In)", Journal of Pharmacopuncture, 5(1), pp.61~79 (2002), 대한약침학회[DOI]